Chinese medical devices maker SyMap Medical has secured nearly $100 million in a new funding round jointly led by Hong Kong-based financial services provider VMS Group and private equity (PE) firm Primavera Capital Group.
Sequoia Capital China, a bellwether of tech investments in China, and healthcare-focused venture capital (VC) firm Simiao Equity Investment also invested in the round.